Phosphoinositide 3-kinase in health and disease Volume 1
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...
| Údar corparáideach: | |
|---|---|
| Rannpháirtithe: | , , |
| Formáid: | Electronic Resource |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Berlin, Heidelberg
Springer
2011.
|
| Sraith: | Current Topics in Microbiology and Immunology
346 |
| Ábhair: | |
| Rochtain ar líne: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |